Tarang Patel, M.D.

Tarang Patel, M.D.
Address:

6620 Coyle Avenue, Suite 414
Carmichael, CA 95608
Ph: 916-961-7391
Fax: 916-961-7393

Post-graduate Training
  • ABIM Fellowship, Nephrology
    Division of Nephrology and Hypertension
    Harbor-UCLA Medical Center, Torrance, CA
    http://www.nephrology.rei.edu/
    July 2007 - June 2009
  • Post-Doctoral NIH Fellowship, Clinical Pharmacology
    Department of Pharmacology and Experimental Therapeutics
    Thomas Jefferson University, Philadelphia, Pennsylvania
    July 2004 - June 2006
  • Residency, Internal Medicine
    Department of Medicine
    Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    July 2002 - June 2004
  • Internship, Internal MedicineDepartment of Medicine
    Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    June 2001 - June 2002
Work Experience:
  • Capital Nephrology Medical Group
    St. George Medical Building
    6620 Coyle Avenue, Ste 414, Carmichael, CA 95608
    http://www.cnmgonline.com/
    August 1, 2009 - Present
  • Hospitalist, Galen Inpatient Physicians
    Regional Medical Center of San Jose
    2100 Powell Street, Suite 900, Emeryville, CA 94606
    July 2006 - June 2007
  • Intermittent Fee-Basis Admitting Physician
    Veteran's Administration, Wilmington, Delaware
    1601 Kirkwood Highway, Wilmington, DE 19805
    July 2004 - June 2006
  • Contract Staff
    Ford Road Campus, Thomas Jefferson University Hospital,
    111 South 11th Street, Suite 2170 Gibbon, Philadelphia, PA 19107
    November 2004 - June 2006
Education:
  • Doctor of Medicine
    St. George’s University School of Medicine, St. George’s, Grenada, West Indies
    May 2001
  • Bachelor of Science in Physiology
    University of California, Davis
    June 1995
Certification:
  • American Board of Nephrology, 2009, expiration 12/2019
  • ECFMG certification: 0-603-943-2, Issue: May 22, 2001, valid indefinitely
Appointments:
  • DaVita Antelope Dialysis Clinic
    Medical Director
    Present
  • DaVita North Highlands Dialysis Clinic
    Medical Director
    Present
  • DaVita North Highlands Home
    Medical Director
    Present
Publications:
  • Manuscript: Patel T, Pequignot E, Parker SH, Leavit MC, Greenberg HE, Kraft WK. Transgenic avian derived glycosylated recombinant human interferon alpha-2b (AVI-005): an open label, controlled, single dose study in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics 2007;45(3):161-68
    March 2007
  • Abstract: “A Rational Approach to Coronary Stenting Prior to Noncardiac Surgery” published in Supplement to Journal of the American College of Cardiology, 2004, Vol. 43, No. 5 (Supplement A) p. 49A-50A
    March 2004
  • Abstract: “Safety of Bivalirudin during Brachytherapy with Beta Radiation”published in The Society for Cardiac Angiography and Interventions, 2003, Vol. 59, No. 1, p. 101-102
    May 2003
  • Abstract: “Genetic Variation in Estrogen Negative Feedback in Male Mice” published in Society for the Study of Reproduction, Biology of Reproduction Journal, 1995, Supplement 1, Vol. 52, p. 74
    July 1995
Presentation:
  • Poster Presentation: “Genetic Variation in Estrogen Negative Feedback in Male mice”  28th Annual Meeting of the Society for the Study of Reproduction University of California, Davis
    July 1995
Clinical Trials Participation:

May 2011: 402-C-0903 – Bardoxolone Methyl Evaluation in patients with Chronic Kidney Disease and Type 2 Diabetes; The Occurrence of Renal Events (BEACON)
Sponsor: Reata Pharmaceuticals, Inc; Naveen Atray, MD as PI; Elena Gelfand, MD, Ratnaji Nallamothu, MD, Matthew Mezger, MD, David Pai, MD, Tarang Patel, MD, Stanley Ruggles, MD and Rohit Kashyap, MD as sub-investigators

August 2011: AFX01-18 – A Phase 3b Single-Arm, Conversion Study from Epoetin alfa to Monthly Peginesatide Injection in Patients with Chronic Kidney Disease on Dialysis.
Sponsor: Affymax, Inc; Naveen Atray, MD as PI; Elena Gelfand, MD, Ratnaji Nallamothu, MD, Matthew Mezger, MD, David Pai, MD, Tarang Patel, MD, Stanley Ruggles, MD and Rahit Kashyap, MD as sub-investigators

July 2013: MK-3102-019 - A Phase III, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-3102 Versus Placebo in Subjects with Type 2 Diabetes Mellitus with Moderate or Severe Chronic Kidney Disease or Kidney Failure on Dialysis Who Have Inadequate Glycemic Control
Sponsor: Merck; Naveen Atray, MD as PI; Elena Gelfand, MD, Ganesh Kambhampati, MD, Tarang Patel, MD, and Ratnaji Nallamothu MD as sub-investigators

Our Locations

CNMG

Capital Nephrology Medical Group

333 University Av., Suite 120

Sacramento, CA 95825

Tel: 916-929-8564

Fax: 916-929-4529



View Office Locations in a larger map

We care about your and your family members' health and helping you make wise care decisions.

Understanding what kind of care you and your family members need is important.

If you think you or your family member has a medical or psychiatric emergency, call 911 or go to the nearest hospital. Do not attempt to access emergency care through this website.